Emerging personalized oncology: Sequencing and systems strategies

Future Oncology

Volumn 8, Issue 6, 2012, Pages 637-641

  Cho, William ^a   Ziogas, Demosthenes E ^b,c   Katsios, Christos ^b,c   Roukos, Dimitrios H ^b,c  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

biomarker; cancer genome; next generation sequencing; personalized oncology; sequencing; transcriptome

Indexed keywords

B RAF KINASE; BRCA1 PROTEIN; BRCA2 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EVEROLIMUS; TRASTUZUMAB; VEMURAFENIB;

APOPTOSIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GENETICS; CANCER RECURRENCE; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL DECISION MAKING; DISEASE COURSE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; HUMAN; OVARY CANCER; OVERALL SURVIVAL; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; REVIEW; SIGNAL TRANSDUCTION; STOMACH CANCER; SURVIVAL RATE; WHOLE GENOME SEQUENCING;

DNA MUTATIONAL ANALYSIS; HUMANS; INDIVIDUALIZED MEDICINE; MEDICAL ONCOLOGY; NEOPLASMS;

EID: 84863645360     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.12.44     Document Type: Review

References (26)

1. Green ED, Guyer MS; National Human Genome Research Institute. Charting a course for genomic medicine from base pairs to bedside. Nature 470(7333), 204-213 (2011).
2. Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature 482(7385), 339-346 (2012).
3. Mirnezami R, Nicholson J, Darzi A. Preparing for precision medicine. N. Engl. J. Med. 366(6), 489-491 (2012).
4. Stratton MR. Exploring the genomes of cancer cells: Progress and promise. Science 331(6024), 1553-1558 (2011).
5. Ding L, Ley TJ, Larson De et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481(7382), 506-510 (2012).
6. Ross-Innes CS, Stark R, Teschendorff AE et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 481(7381), 389-393 (2012).
7. Roychowdhury S, Iyer MK, Robinson DR et al. Personalized oncology through integrative high-throughput sequencing: A pilot study. Sci. Transl Med. 3(111), 111ra121 (2011).
8. Phimister EG, Feero WG, Guttmacher AE. Realizing genomic medicine. N. Engl. J. Med. 366(8), 757-759 (2012).
9. Hudson TJ, Anderson W, Artez A et al.; International Cancer Genome Consortium. International network of cancer genome projects. Nature 464(7291), 993-998 (2010).
10. Boekhout AH, Beijnen JH, Schellens JH. Trastuzumab. Oncologist 16(6), 800-810 (2011).
11. Chapman PB, Hauschild A, Robert C et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N. Engl. J. Med. 364(26), 2507-2516 (2011).
12. Fabbro D, Cowan-Jacob SW, Möbitz H, Martiny-Baron G. Targeting cancer with small-molecular-weight kinase inhibitors. Methods Mol. Biol. 795, 1-34 (2012).
13. Baselga J, Campone M, Piccart M. Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. N. Engl. J. Med. 366(6), 520-529 (2012).
14. Baselga J, Cortés J, Kim SB et al. Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer. N. Engl. J. Med. 366(2), 109-119 (2012).
15. Lam HY, Clark MJ, Chen R et al. Performance comparison of whole-genome sequencing platforms. Nat. Biotechnol. 30(1), 78-82 (2011).
16. Wang MD. In the spotlight: Bioinformatics, computational biology and systems biology. IEEE Rev. Biomed. Eng. 4, 3-5 (2011).
17. Ding L, Ellis MJ, Li S et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464, 999-1005 (2010).
18. Yachida S, Jones S, Bozic I et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114-1117 (2010).
19. Navin N, Kendall J, Troge J et al. Tumour evolution inferred by single-cell sequencing. Nature 472, 90-94 (2011).
20. Ideker T, Krogan NJ. Differential network biology. Mol. Syst. Biol. 8, 565 (2012).
21. Baker DJ, Wijshake T, Tchkonia T et al. Clearance of p16Ink4a-positive senescent cells delays ageing-Associated disorders. Nature 479(7372), 232-236 (2011).
22. Baylin SB, Jones PA. A decade of exploring the cancer epigenome - biological and translational implications. Nat. Rev. Cancer 11(10), 726-734 (2011).
23. Roukos DH, Katsios C, Liakakos T. Genotype-phenotype map and molecular networks: A promising solution in overcoming colorectal cancer resistance to targeted treatment. Expert Rev. Mol. Diagn. 10(5), 541-545 (2010).
24. Katsios C, Roukos DH. Individual genomes and personalized medicine: Life diversity and complexity. Pr. Med. 7(4), 347-350 (2010).
25. Roukos DH. Complete genome sequencing and network modeling to overcome trastuzumab resistance. Pharmacogenomics 11(8), 1039-1043 (2010).
26. Roukos DH. Next-generation, genome sequencing-based biomarkers: Concerns and challenges for medical practice. Biomark. Med. 4(4), 583-586 (2010)